[Investigation of a new product (HK 183 MB) in various dermatoses].
The new trial preparation, diflucortolone valerate, was tested clinically in the form of a cream on 41 patients with weeping dermatitis. 34 cases were treated without a dressing, 5 with a dressing and 2 with an occlusive dressing. A complete cure or a distinct improvement was obtained in 100% of the cases. No undesired side effects developed.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D009824:Ointments; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D009824:Ointments; D014631:Valerates
Investigacion dd un nuevo producto (SHK 183 MB) en diversas dermatósis